| Symbol | MBPG |
|---|---|
| Name | MARELIUS, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | WC2R 0DT United Kingdom ENG 80 Strand Shell-Mex House, |
| Telephone | +44 7932167872 |
| Fax | — |
| — | |
| Website | http://www.argq.io |
| Incorporation | US |
| Incorporated On | 2010 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | SSM Business Solutions Corporation; |
| Audit Status | UNAUDITED |
| Reporting Status | Alternative Reporting Standard |
| CIK | 0001533106 |
| Description | Argentum 47, Inc. is a diversified holding company located in Nevada, United States with market positions in the United Kingdom, United States. Its sole subsiary Marelius Biopharma Group is a specialized company dedicated to enhancing knowledge in the biopharma and pharmaceutical industries. Based in the UK, the company operates globally, offering virtual and in-person training, including customized sessions conducted at client sites. The company is in the process of establishing a state-of-the-art training facility that integrates clinical manufacturing capabilities, enabling professionals to gain hands-on, practical experience. Marelius focuses on enhancing industry knowledge, supporting professional development, and driving innovation within pharmaceutical and biopharmaceutical manufacturing processes. Through tailored educational initiatives, Marelius Biopharma Group empowers industry professionals to excel in their roles and fosters advancements across the sector. Additional info from OTC: |
No news found.